MISSISSAUGA, ON, Sept. 8, 2017 /CNW/ – MyndTec, an award-winning Canadian medical technology company announced today it has received 510(k) clearance to market its landmark product MyndMove®. MyndTec is a pioneer in the treatment of arm and hand paralysis caused by stroke or spinal cord injury.
“This is a major milestone in the evolution of our company,” said MyndTec Founder Dr. Milos R. Popovic. “We are delighted that we can now offer this life-changing therapy to patients in the U.S. with upper extremity paralysis.”
MyndTec intends to initiate a pilot launch of MyndMove® into the U.S. market which complements a product introduction already underway in Canada with a previously announced approval from Health Canada.
MyndMove® Therapy is a functional electric stimulation (FES) based intervention. The system offers therapists the ability to assist individuals with upper limb paralysis to improve voluntary control of their arms and hands. The MyndMove® therapy system offers over 30 FES protocols that therapists use to enable meaningful controlled movements via proprietary stimulation technology.
MyndTec Inc. (formerly Simple Systems Inc.) is a privately held medical technology company located in Mississauga, Ontario, that develops and commercializes innovative therapeutic medical devices designed to improve function, maximize independence and enhance quality of life. MyndTec was founded in 2008 as Simple Systems Inc., to commercialize technology developed by Dr. Milos R. Popovic and his colleagues at the Toronto Rehabilitation Institute-University Health Network and the Institute of Biomaterials and Biomedical Engineering at the University of Toronto.
For more information on MyndTec and MyndMove® and authorized indications, please visit http://www.myndtec.com. The contents of the website are specifically not incorporated by reference in this press release.
SOURCE MyndTec Inc.
For further information: Steven Plymale, MyndTec Inc., 905-363-0564, Steven.Plymale@myndtec.com